Herlev and Gentofte Hospital — Herlev

Public research footprint of Herlev and Gentofte Hospital, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Implant Site Pocket Infection · Heart Failure With Mildly Reduced Ejection Fraction · Non-Muscle Invasive Bladder Neoplasms · Atherosclerotic Cardiovascular Disease (ASCVD)

Recently updated registry entries

NCT07405164 — Extension Study for Participants in Studies That Include Belzutifan… (Recruiting)
NCT07064473 — EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin… (Recruiting)
NCT06077864 — A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People… (Completed)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Herlev and Gentofte Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 04, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.